Healthcare & Biotechnology
Our coverage
- Ablynx NV
- Allergy Therapeutics plc
- Antisoma plc
- Care UK plc
- CareTech Holdings plc
- Corin Group plc
- Genus plc *
- GW Pharmaceuticals plc
- Healthcare Locums plc *
- IP Group plc *
- Optos plc
- Osmetech plc
- Oxford Biomedica plc
- Phytopharm plc *
- Protherics plc
- Renovo plc
- Southern Cross Healthcare Group plc
- Synergy Healthcare plc
Our people
- An overview of the people involved in Healthcare & Biotechnology.
- Healthcare & Biotechnology people
Contacts
- Email our team
- healthcare@kbcpeelhunt.com
We are the only fully integrated house to follow Healthcare, Medical Technology and Biotechnology in tandem. Each has a huge part to play in the others’ future success and development. With a specialist team dedicated to these areas, we are in a strong position to advise both corporate and institutional investors on important trends, developments and ultimately investments.
The key issues driving the medium terms outlook are the ageing population, NHS reform and a record year for new drug applications and approvals. Our team are well positioned to capture the changes in dynamics, trends and issues that could ultimately affect all of our lives.
Back
- We have experience in fund management, working in the NHS, in Biotech and in big pharmaceutical companies.
- We research 14 stocks in the sector.
- We make markets in over 30 stocks in the sector.
- Since March 2004, we have completed corporate transactions totalling over £110 million.
